NAKA - NASDAQ

Nakamoto Inc.

NAKA·NASDAQ

$4.96

+0.58%

Financial ServicesFinancial - Capital Markets

Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$4.76B

EPS-0.2600

P/E Ratio-19.08

Earnings Date06/03/2026

-23.51M

Operating Cash Flow

665%

3Y+16648.0%

5Y-19460.0%

10Y-19460.0%

-680.02M

Investing Cash Flow

169216%

3Y+214157.0%

5Y+1069087.0%

10Y+1069087.0%

723.85M

Financing Cash Flow

13757%

3Y+131508.0%

5Y-1596548.0%

10Y-1596548.0%

Nakamoto Inc. Cash Conversion Engine

NAKA · NASDAQ

FCF Components

Net Income-52.23M

Depreciation & Amortization241.99K

Stock-Based Compensation2.36M

Change in Working Capital-4.05M

Others30.17M

Capital Expenditures-696.48M

Free Cash Flow-719.99M

Cash Flow Quality Analysis

FCF Conversion Rate

1378.5%

Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.

CapEx Intensity

-2962.3%

Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.

FCF Growth Trend

-20616.1%

Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.

Working Capital Impact

-$4.05M

Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.

Cash Flow Quality Insight

Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.

Nakamoto Inc. Cash Flow Statement

NAKA • NASDAQ

Nakamoto Inc. Cash Flow Statement	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
OPERATING ACTIVITIES
Net Income	-52.2M	-3.6M	-1.6M	-2.5M	149.3K
Depreciation & Amortization	242K	220.3K	203.2K	122K	63.4K
Stock-Based Compensation	2.4M	161.3K	414.7K	2.2M	0.0
Other Non-Cash Items	30.2M	464.1K	433.7K	28.6K	0.0
Change in Working Capital	-4.1M	-302K	116.4K	33.2K	-91.3K
Cash from Operating Activities	-23.5M	-3.1M	-449.5K	-140.4K	121.4K
INVESTING ACTIVITIES
Investments in Property, Plant, and Equipment	-696.5M	-13.3K	-14.4K	-317.4K	-63.6K
Acquisitions, Net	-29.8M	(0.0)	(0.0)	(0.0)	(0.0)
Sale/Maturity of Investments	46.3M	0.0	0.0	0.0	0.0
Other Investing Items	0.0	-388.3K	0.0	0.0	0.0
Cash from Investing Activities	-680M	-401.6K	-14.4K	-317.4K	-63.6K
FINANCING ACTIVITIES
Net Issuance of Common Stock	532.6M	5.8M	0.0	400K	2K
Net Issuance of Debt	191.2M	-614.9K	802.5K	150K	-47.3K
Share Repurchases	-320.4K	-22.1K	(0.0)	(0.0)	(0.0)
Cash from Financing Activities	723.8M	5.2M	802.5K	550K	-45.3K
CASH FLOW SUMMARY
Net Change in Cash	20.3M	1.7M	338.6K	92.2K	12.5K
Cash at Beginning of Period	2.3M	525.5K	186.9K	94.7K	82.2K
Cash at End of Period	22.6M	2.3M	525.5K	186.9K	94.7K
Free Cash Flow	-720M	-3.5M	-463.9K	-457.8K	57.8K

SEC Filings

NAKA - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 22, 2026	May 21, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 13, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 13, 2026	May 13, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 12, 2026	May 08, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 07, 2026	May 04, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 17, 2026	April 17, 2026	2026	View Filing
S-3/A S-3/A (Amended) N/A	April 17, 2026	April 17, 2026		View Filing
S-3/A S-3/A (Amended) N/A	April 17, 2026	April 17, 2026		View Filing
S-3 S-3 N/A	April 09, 2026	April 09, 2026		View Filing
S-3 S-3 N/A	April 09, 2026	April 09, 2026		View Filing

Showing 1 to 10 of 69 filings

Related Guides

Blog Categories

Continue your NAKA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.